Cargando…
Acutely Inhibiting AQP4 With TGN-020 Improves Functional Outcome by Attenuating Edema and Peri-Infarct Astrogliosis After Cerebral Ischemia
BACKGROUND: Ischemic stroke is one of the leading causes of human death and disability. Brain edema and peri-infarct astrocyte reactivity are crucial pathological changes, both involving aquaporin-4 (AQP4). Studies revealed that acute inhibition of AQP4 after stroke diminishes brain edema, however,...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110854/ https://www.ncbi.nlm.nih.gov/pubmed/35592320 http://dx.doi.org/10.3389/fimmu.2022.870029 |
_version_ | 1784709195754373120 |
---|---|
author | Sun, Chengfeng Lin, Luyi Yin, Lekang Hao, Xiaozhu Tian, Jiaqi Zhang, Xiaoxue Ren, Yan Li, Chanchan Yang, Yanmei |
author_facet | Sun, Chengfeng Lin, Luyi Yin, Lekang Hao, Xiaozhu Tian, Jiaqi Zhang, Xiaoxue Ren, Yan Li, Chanchan Yang, Yanmei |
author_sort | Sun, Chengfeng |
collection | PubMed |
description | BACKGROUND: Ischemic stroke is one of the leading causes of human death and disability. Brain edema and peri-infarct astrocyte reactivity are crucial pathological changes, both involving aquaporin-4 (AQP4). Studies revealed that acute inhibition of AQP4 after stroke diminishes brain edema, however, its effect on peri-infarct astrocyte reactivity and the subacute outcome is unclear. And if diffusion-weighted imaging (DWI) could reflect the AQP4 expression patterns is uncertain. METHODS: Rats were subjected to middle cerebral artery occlusion (MCAO) and allocated randomly to TGN 020-treated and control groups. One day after stroke, brain swelling and lesion volumes of the rats were checked using T2-weighted imaging (T2-WI). Fourteen days after stroke, the rats successively underwent neurological examination, T2-WI and DWI with standard b-values and ultra-high b-values, apparent diffusion coefficient (ADC) was calculated correspondingly. Finally, the rats’ brains were acquired and used for glial fibrillary acidic protein (GFAP) and AQP4 immunoreactive analysis. RESULTS: At 1 day after stroke, the TGN-020-treated animals exhibited reduced brain swelling and lesion volumes compared with those in the control group. At 14 days after stroke, the TGN-020-treated animals showed fewer neurological function deficits and smaller lesion volumes. In the peri-infarct region, the control group showed evident astrogliosis and AQP4 depolarization, which were reduced significantly in the TGN-020 group. In addition, the ultra-high b-values of ADC (ADCuh) in the peri-infarct region of the TGN-020 group was higher than that of the control group. Furthermore, correlation analysis revealed that peri-infarct AQP4 polarization correlated negatively with astrogliosis extent, and ADCuh correlated positively with AQP4 polarization. CONCLUSION: We found that acutely inhibiting AQP4 using TGN-020 promoted neurological recovery by diminishing brain edema at the early stage and attenuating peri-infarct astrogliosis and AQP4 depolarization at the subacute stage after stroke. Moreover, ADCuh could reflect the AQP4 polarization. |
format | Online Article Text |
id | pubmed-9110854 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91108542022-05-18 Acutely Inhibiting AQP4 With TGN-020 Improves Functional Outcome by Attenuating Edema and Peri-Infarct Astrogliosis After Cerebral Ischemia Sun, Chengfeng Lin, Luyi Yin, Lekang Hao, Xiaozhu Tian, Jiaqi Zhang, Xiaoxue Ren, Yan Li, Chanchan Yang, Yanmei Front Immunol Immunology BACKGROUND: Ischemic stroke is one of the leading causes of human death and disability. Brain edema and peri-infarct astrocyte reactivity are crucial pathological changes, both involving aquaporin-4 (AQP4). Studies revealed that acute inhibition of AQP4 after stroke diminishes brain edema, however, its effect on peri-infarct astrocyte reactivity and the subacute outcome is unclear. And if diffusion-weighted imaging (DWI) could reflect the AQP4 expression patterns is uncertain. METHODS: Rats were subjected to middle cerebral artery occlusion (MCAO) and allocated randomly to TGN 020-treated and control groups. One day after stroke, brain swelling and lesion volumes of the rats were checked using T2-weighted imaging (T2-WI). Fourteen days after stroke, the rats successively underwent neurological examination, T2-WI and DWI with standard b-values and ultra-high b-values, apparent diffusion coefficient (ADC) was calculated correspondingly. Finally, the rats’ brains were acquired and used for glial fibrillary acidic protein (GFAP) and AQP4 immunoreactive analysis. RESULTS: At 1 day after stroke, the TGN-020-treated animals exhibited reduced brain swelling and lesion volumes compared with those in the control group. At 14 days after stroke, the TGN-020-treated animals showed fewer neurological function deficits and smaller lesion volumes. In the peri-infarct region, the control group showed evident astrogliosis and AQP4 depolarization, which were reduced significantly in the TGN-020 group. In addition, the ultra-high b-values of ADC (ADCuh) in the peri-infarct region of the TGN-020 group was higher than that of the control group. Furthermore, correlation analysis revealed that peri-infarct AQP4 polarization correlated negatively with astrogliosis extent, and ADCuh correlated positively with AQP4 polarization. CONCLUSION: We found that acutely inhibiting AQP4 using TGN-020 promoted neurological recovery by diminishing brain edema at the early stage and attenuating peri-infarct astrogliosis and AQP4 depolarization at the subacute stage after stroke. Moreover, ADCuh could reflect the AQP4 polarization. Frontiers Media S.A. 2022-05-03 /pmc/articles/PMC9110854/ /pubmed/35592320 http://dx.doi.org/10.3389/fimmu.2022.870029 Text en Copyright © 2022 Sun, Lin, Yin, Hao, Tian, Zhang, Ren, Li and Yang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Sun, Chengfeng Lin, Luyi Yin, Lekang Hao, Xiaozhu Tian, Jiaqi Zhang, Xiaoxue Ren, Yan Li, Chanchan Yang, Yanmei Acutely Inhibiting AQP4 With TGN-020 Improves Functional Outcome by Attenuating Edema and Peri-Infarct Astrogliosis After Cerebral Ischemia |
title | Acutely Inhibiting AQP4 With TGN-020 Improves Functional Outcome by Attenuating Edema and Peri-Infarct Astrogliosis After Cerebral Ischemia |
title_full | Acutely Inhibiting AQP4 With TGN-020 Improves Functional Outcome by Attenuating Edema and Peri-Infarct Astrogliosis After Cerebral Ischemia |
title_fullStr | Acutely Inhibiting AQP4 With TGN-020 Improves Functional Outcome by Attenuating Edema and Peri-Infarct Astrogliosis After Cerebral Ischemia |
title_full_unstemmed | Acutely Inhibiting AQP4 With TGN-020 Improves Functional Outcome by Attenuating Edema and Peri-Infarct Astrogliosis After Cerebral Ischemia |
title_short | Acutely Inhibiting AQP4 With TGN-020 Improves Functional Outcome by Attenuating Edema and Peri-Infarct Astrogliosis After Cerebral Ischemia |
title_sort | acutely inhibiting aqp4 with tgn-020 improves functional outcome by attenuating edema and peri-infarct astrogliosis after cerebral ischemia |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110854/ https://www.ncbi.nlm.nih.gov/pubmed/35592320 http://dx.doi.org/10.3389/fimmu.2022.870029 |
work_keys_str_mv | AT sunchengfeng acutelyinhibitingaqp4withtgn020improvesfunctionaloutcomebyattenuatingedemaandperiinfarctastrogliosisaftercerebralischemia AT linluyi acutelyinhibitingaqp4withtgn020improvesfunctionaloutcomebyattenuatingedemaandperiinfarctastrogliosisaftercerebralischemia AT yinlekang acutelyinhibitingaqp4withtgn020improvesfunctionaloutcomebyattenuatingedemaandperiinfarctastrogliosisaftercerebralischemia AT haoxiaozhu acutelyinhibitingaqp4withtgn020improvesfunctionaloutcomebyattenuatingedemaandperiinfarctastrogliosisaftercerebralischemia AT tianjiaqi acutelyinhibitingaqp4withtgn020improvesfunctionaloutcomebyattenuatingedemaandperiinfarctastrogliosisaftercerebralischemia AT zhangxiaoxue acutelyinhibitingaqp4withtgn020improvesfunctionaloutcomebyattenuatingedemaandperiinfarctastrogliosisaftercerebralischemia AT renyan acutelyinhibitingaqp4withtgn020improvesfunctionaloutcomebyattenuatingedemaandperiinfarctastrogliosisaftercerebralischemia AT lichanchan acutelyinhibitingaqp4withtgn020improvesfunctionaloutcomebyattenuatingedemaandperiinfarctastrogliosisaftercerebralischemia AT yangyanmei acutelyinhibitingaqp4withtgn020improvesfunctionaloutcomebyattenuatingedemaandperiinfarctastrogliosisaftercerebralischemia |